主页文献库搜索
Characterization of different CTC subpopulations in non-small cell lung cance...

Hanssen(Annkathrin),Wagner(Jenny),Gorges(T... Sci Rep 0000-00-00

...PIK3CA, AKT2, TWIST, and ALDH1 following EGFR, HER2 and EpCAM based enrichment detected CTCs in 29% of the patients. Int...

Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More...

Cohen(Stacey A),Turner(Emily H),Beightol(M... Gastroenterology 0000-00-00

...PIK3CA; mutations in PIK3CA are detected at substantially higher frequencies in these double somatic tumors than in othe...

Heterogeneity of resistance mutations detectable by nextgeneration sequencing...

Belchis(Deborah A),Tseng(Li-Hui),Gniadek(T... Oncotarget 0000-00-00

...PIK3CA mutations in 10 (26%), EGFR p.S768_V769delinsIL in one, and KRAS p.G12C in one. Five PIK3CA mutations were outsid...

The role of aspirin in colorectal cancer chemoprevention.

Singh Ranger(Gurpreet) Crit Rev Oncol Hematol 0000-00-00

...PIK3CA pathway, or therapy-induced senescence of cancer cells. The most serious side effect of prolonged aspirin treatme...

Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and met...

Ross(Jeffrey S),Gay(Laurie M),Wang(Kai),Al... Cancer 0000-00-00

...PIK3CA) (42%); cadherin 1, type 1 (CDH1) (37%); MYC (17%); and cyclin D1 protein (CCND1) (16%). CDH1 mutations were enri...

Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: O...

Módos(Orsolya),Reis(Henning),Niedworok(Chr... Oncotarget 0000-00-00

...PIK3CA genes. No correlation was found between the mutation status and clinicopathological parameters (Sheldon/Mayo stag...

A microscopic landscape of the invasive breast cancer genome.

Ping(Zheng),Xia(Yuchao),Shen(Tiansheng),Pa... Sci Rep 0000-00-00

...PIK3CA mutations and MYC amplification. A distinct genetic interaction among these genomic abnormalities was revealed as...

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resi...

Chabon(Jacob J),Simmons(Andrew D),Lovejoy(... Nat Commun 0000-00-00

...PIK3CA, ERRB2, KRAS and RB1. We describe a novel EGFR L798I mutation and find that EGFR C797S, which arises in ∼33% of p...

Comprehensive Genomic Profiling Facilitates Implementation of the National Co...

Suh(James H),Johnson(Adrienne),Albacker(Le... Oncologist 0000-00-00

...PIK3CA (5.4%), CDK4 (4.3%), CCND1 (4.0%), BRCA2 (2.5%), NRAS (2.3%), BRCA1 (1.7%), MAP2K1 (1.2%), HRAS (0.7%), NTRK1 (0....

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cel...

Li(Y),Bouchlaka(M N),Wolff(J),Grindle(K M)... Oncogene 0000-00-00

...PIK3CA and BAFF-R. Targeting BCL2 by the specific inhibitor ABT-199 synergized with ibrutinib in inhibiting growth of bo...

上一页 329 330 331 332 333 334 335 336 337 下一页 333 / 共 350

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com